Depression and Eosinophil count decreased

Summary:

Eosinophil count decreased is found among people with Depression, especially for people who are female, 50-59 old.

The study analyzes which people have Eosinophil count decreased with Depression. It is created by eHealthMe based on reports of 74 people who have Depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Depression?

Depression is found to be associated with 3,167 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.

What is Eosinophil count decreased?

Eosinophil count decreased is found to be associated with 274 drugs and 472 conditions by eHealthMe. Check the latest studies of Eosinophil count decreased.



On Jul, 13, 2026

74 people who have Depression and Eosinophil Count Decreased are studied.

Would you have Eosinophil count decreased when you have Depression?

Gender of people who have Depression and experienced Eosinophil Count Decreased *:

  • female: 61.43 %
  • male: 38.57 %

Age of people who have Depression and experienced Eosinophil Count Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.03 %
  • 20-29: 4.55 %
  • 30-39: 19.7 %
  • 40-49: 22.73 %
  • 50-59: 42.42 %
  • 60+: 7.58 %

Common co-existing conditions for these people *:

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 23 people, 31.08%
  2. Sleep Disorder: 22 people, 29.73%
  3. Pain: 17 people, 22.97%
  4. Mood Swings (an extreme or rapid change in mood): 14 people, 18.92%
  5. Muscle Spasms (muscle contraction): 13 people, 17.57%
  6. Diabetes: 13 people, 17.57%
  7. Stress And Anxiety: 11 people, 14.86%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 13.51%
  9. Upper Respiratory Tract Infection: 9 people, 12.16%
  10. Dyspnea (difficult or laboured breathing): 9 people, 12.16%

Common drugs taken by these people *:

  1. Clozaril: 29 people, 39.19%
  2. Folic Acid: 26 people, 35.14%
  3. Zyprexa: 19 people, 25.68%
  4. Amoxicillin: 19 people, 25.68%
  5. Effexor: 18 people, 24.32%
  6. Ativan: 18 people, 24.32%
  7. Gilenya: 15 people, 20.27%
  8. Clonazepam: 15 people, 20.27%
  9. Flexeril: 14 people, 18.92%
  10. Femara: 14 people, 18.92%

Common symptoms for these people *:

  1. Lymphocyte Count Decreased: 35 people, 47.30%
  2. White Blood Cell Count Decreased: 33 people, 44.59%
  3. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 32 people, 43.24%
  4. Haemoglobin Decreased: 30 people, 40.54%
  5. Red Blood Cell Count Decreased: 29 people, 39.19%
  6. Haematocrit Decreased: 29 people, 39.19%
  7. Blood Glucose Increased: 28 people, 37.84%
  8. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 28 people, 37.84%
  9. Thrombocytopenia (decrease of platelets in blood): 27 people, 36.49%
  10. Monocyte Count Decreased: 23 people, 31.08%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eosinophil count decreased?

- Check whether Eosinophil count decreased is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Eosinophil count decreased:

All the conditions that are associated with Eosinophil count decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eosinophil count decreased and Depression, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: